IDH1 and central nervous system cancer: In grade II and grade III lower-grade gliomas (LrGGs), IDH1 wild-type group showed significantly lower ADC, D, f, DDC, α, and MD values (P < 0.05) and higher D∗, MK, and ICVF values (P < 0.05) than IDH1-mutant group.